Andrew McLachlan

Professor of Pharmacy (Aged Care), University of Sydney

Professor Andrew McLachlan is the Program Director of the NHMRC Centre for Research Excellence in Medicines and Ageing, at the Faculty of Pharmacy and at Concord Hospital’s Centre for Education and Research on Ageing. He is a pharmacist, academic and researcher experienced in clinical and experimental pharmacology and research on the quality use of medicines. His research focuses on understanding the variability in response to medicines and how this can be managed to optimise patient care, particularly in special patient populations such as older people, the very young and the critically ill. He is interested in translating clinical pharmacology research into real-world practice. . Andrew is Chair of the Sydney Local Health District Human Research Ethics Committee at Concord Hospital and the Drug and Therapeutics Committee, an Advisory Committee Member of the Ageing and Alzheimer’s Institute at Concord Hospital, and past President of the Australasian Pharmaceutical Science Association (APSA). He has serves on expert panels related to medicines regulation and antidoping. Andrew was appointed the inaugural Chair of the National Medicines Policy Committee (2009-2013) by the Minister for Health and Ageing. He was awarded Pharmacist of the Year (2006) by the Pharmaceutical Society of Australia, and received the 2013 Australasian Pharmaceutical Science Association APSA medal, the association’s highest award. He is an Executive Editor of the British Journal of Clinical Pharmacology.

Experience

  • –present
    Professor of Pharmacy (Aged Care), University of Sydney